{"filing":{"accession_number":"0001437749-26-025252","cik":"0001716621","ticker":"VTAK","company_name":"Catheter Precision, Inc.","form":"8-K","filing_date":"2026-07-31","report_date":"2026-07-27","primary_document":"vtak20260727_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1716621/000143774926025252/vtak20260727_8k.htm"},"events":[{"id":22495,"run_id":20351,"accession_number":"0001437749-26-025252","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Catheter Precision closed a Series C-4 Convertible Preferred Stock offering on July 30, 2026, issuing 2,821 shares for $2.821 million in gross proceeds under Section 4(a)(2) and Regulation D Rule 506(b) exemptions. Conversion of the Series C-4 Preferred Stock into Common Stock will result in dilution of existing Common Stock holders, with the preferred shares carrying senior ranking with respect to dividends and liquidation preferences.","company_name":"Catheter Precision, Inc.","ticker":"VTAK","filing_date":"2026-07-31","form":"8-K","submitted_at":null,"items":[{"id":22452,"accession_number":"0001437749-26-025252","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a classic dilutive_issuance disclosure under Item 3.02. Catheter Precision closed a Series C-4 Convertible Preferred Stock offering on July 30, 2026, issuing 2,821 shares for $2.821 million in gross proceeds. The securities were issued in reliance on Section 4(a)(2) and Regulation D Rule 506(b) exemptions from registration, with accredited investors acquiring for investment only. The convertible preferred structure and unregistered nature are hallmarks of a dilutive private placement typical of small- and mid-cap companies raising capital.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:30:04.404939+00:00","company_name":"","ticker":null,"filing_date":""},{"id":22453,"accession_number":"0001437749-26-025252","item_number":"3.03","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The disclosure describes issuance of Series C-4 Preferred Stock that will result in dilution of existing Common Stock holders upon conversion. The explicit statement that \"conversion of the Series C-4 Preferred Stock into Common Stock will result in dilution of the existing holders of Common Stock\" is the key indicator of a dilutive issuance. The senior ranking with respect to dividends and liquidation preferences further confirms this is a material capital structure change affecting existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:30:04.404939+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":22496,"run_id":20351,"accession_number":"0001437749-26-025252","anchor_item_number":"5.03","event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.75,"summary":"The Company filed a Series C-4 Certificate of Designation with the Delaware Secretary of State on July 27, 2026, amending its articles of incorporation to designate the terms and conditions of the new preferred stock series.","company_name":"Catheter Precision, Inc.","ticker":"VTAK","filing_date":"2026-07-31","form":"8-K","submitted_at":null,"items":[{"id":22454,"accession_number":"0001437749-26-025252","item_number":"5.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.75,"reasoning":"The filing discloses an amendment to the Company's articles of incorporation through the filing of a Series C-4 Certificate of Designation with the Delaware Secretary of State on July 27, 2026. This is a routine governance/structural matter involving the designation of a new series of preferred stock. While such designations can have capital structure implications, the disclosure itself is administrative in nature and does not indicate a material capital event, dilutive issuance, or change in control—it is simply the formal documentation of preferred stock terms.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:30:04.404939+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22452,"accession_number":"0001437749-26-025252","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a classic dilutive_issuance disclosure under Item 3.02. Catheter Precision closed a Series C-4 Convertible Preferred Stock offering on July 30, 2026, issuing 2,821 shares for $2.821 million in gross proceeds. The securities were issued in reliance on Section 4(a)(2) and Regulation D Rule 506(b) exemptions from registration, with accredited investors acquiring for investment only. The convertible preferred structure and unregistered nature are hallmarks of a dilutive private placement typical of small- and mid-cap companies raising capital.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:30:04.404939+00:00","company_name":"Catheter Precision, Inc.","ticker":"VTAK","filing_date":"2026-07-31"},{"id":22453,"accession_number":"0001437749-26-025252","item_number":"3.03","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The disclosure describes issuance of Series C-4 Preferred Stock that will result in dilution of existing Common Stock holders upon conversion. The explicit statement that \"conversion of the Series C-4 Preferred Stock into Common Stock will result in dilution of the existing holders of Common Stock\" is the key indicator of a dilutive issuance. The senior ranking with respect to dividends and liquidation preferences further confirms this is a material capital structure change affecting existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:30:04.404939+00:00","company_name":"Catheter Precision, Inc.","ticker":"VTAK","filing_date":"2026-07-31"},{"id":22454,"accession_number":"0001437749-26-025252","item_number":"5.03","item_title":null,"event_type":"governance_other","event_domain":"governance","is_material":false,"confidence":0.75,"reasoning":"The filing discloses an amendment to the Company's articles of incorporation through the filing of a Series C-4 Certificate of Designation with the Delaware Secretary of State on July 27, 2026. This is a routine governance/structural matter involving the designation of a new series of preferred stock. While such designations can have capital structure implications, the disclosure itself is administrative in nature and does not indicate a material capital event, dilutive issuance, or change in control—it is simply the formal documentation of preferred stock terms.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:30:04.404939+00:00","company_name":"Catheter Precision, Inc.","ticker":"VTAK","filing_date":"2026-07-31"}]}